Introduction {#S5}
============

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States.([@R1]) NAFLD refers to a broad spectrum of liver injury from simple steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. Large population based studies have demonstrated associations between NAFLD and increased all-cause and liver-related mortality;([@R2], [@R3]) however, there are no medical therapies available.

Currently, the cornerstone of treatment for NAFLD involves lifestyle interventions including increasing physical activity (PA).([@R4]) The relationship between PA and NAFLD, independent of weight loss, has not been well characterized. In several small studies of exercise programs, liver fat content diminishes ([@R5], [@R6], [@R7]) and intrahepatic triglyceride content decreases ([@R8]) with exercise independent of weight loss. A randomized controlled trial in obese patients found that the addition of physical activity to a diet-induced weight loss program promoted greater reductions in waist circumference and hepatic fat content.([@R9]) The literature is still somewhat conflicting, as some studies show no improvement in histologic features of NASH with circuit exercise training.([@R10]) The optimal dose of PA by intensity and duration for the prevention and treatment of NAFLD has not been well established. Prior population-based studies of the association of PA and NAFLD have been limited by the lack of objectively obtained PA data, with most studies relying on self-report, patient recall or leisure time only activities.([@R11], [@R12], [@R13], [@R14]) The one population based study using accelerometer derived physical activity measurements found that participants with NAFLD were less physically active than participants without NAFLD. ([@R15]) However, this study defined NAFLD based on the Fatty Liver Index which does not incorporate imaging data and has been shown to have limited utility in detecting hepatic steatosis in obese patients.([@R16]) In addition, there is emerging evidence that prolonged sedentary time, independent of PA, may be associated with cardiometabolic risk factors and overall mortality, but the associations with NAFLD has not been specifically evaluated.([@R17], [@R18], [@R19])

Thus, the purpose of the present study was to determine the association between objectively measured PA using accelerometry and hepatic steatosis in a large community-based sample. We hypothesized that participants with higher levels of PA would have a lower prevalence of hepatic steatosis. We also evaluated whether an association exists between sedentary time and hepatic steatosis. Finally, we assessed whether associations were stronger in participants who met the national PA guidelines of ≥150 minutes of moderate-to-vigorous PA (MVPA) per week in total or accumulated in bouts of ≥10 minutes.([@R20])

Patients and Methods {#S6}
====================

Additional methodological details are available in the [online supplement](#SD1){ref-type="supplementary-material"}.

Study sample {#S7}
------------

The Framingham Heart Study (FHS) is a multi-generational cohort study. Our sample was derived from a total of 3732 participants in the Third Generation Cohort and Omni 2 Cohort of the FHS who attended the second examination cycle (May 2008 to March 2011) when accelerometry was performed. Individuals were excluded from this analysis if they did not participate in the Multi-Detector CT 2 substudy (n=2162) or their CT scans were not interpretable for liver attenuation or Visceral Adipose Tissue (VAT) (n=14), they did not participate in accelerometry (n=239) or had insufficient accelerometry data (n=75), they had missing serum aminotransferase levels (n=5), incomplete covariate data (n=1) or significant alcohol use defined as \> 7 drinks per week for women and \> 14 drinks per week for men (n=176), yielding a total sample of 1,060 participants. The institutional review boards of the Boston University Medical Center and Massachusetts General Hospital approved the study protocol.

Measurement of physical activity by accelerometer {#S8}
-------------------------------------------------

During the second examination cycle between May 2008 to March 2011, Third Generation and Omni Cohort 2 participants were instructed to wear an omnidirectional accelerometer (Actical Model No. 198-0200-00; Philips Respironics, Bend, OR) on a waist-worn belt 24 hours/day for 8 days (to allow for 7 full days of wear time) as previously described.([@R21])

Multi-detector CT scan protocol and measurement of VAT and liver attenuation {#S9}
----------------------------------------------------------------------------

Multi-detector CT scans were conducted in a substudy of FHS participants from September 2008 to December 2011 as previously described.([@R22]) We defined hepatic steatosis as a liver phantom ratio of ≤ 0.33 based our prior work.([@R23])

Covariate and baseline measurements {#S10}
-----------------------------------

Covariate and baseline measurements were measured at the second examination cycle (May 2008 to March 2011) for the Third Generation and Omni Cohort 2 participants when accelerometry was also routinely performed.

Statistical analysis {#S11}
--------------------

To describe the characteristics of the analysis population, we used means with standard deviations for continuous traits and percentages for categorical traits. Sex-specific, age-adjusted Pearson correlation coefficients between PA categories (sedentary, light, MVPA and MVPA bouts) and metabolic parameters were calculated. Multivariable logistic regression models were used to assess the cross-sectional association with PA (per 30 minutes/day increase in PA or compliance with national PA guidelines) and hepatic steatosis as measured by multi-detector CT scan. An additional multivariable logistic regression model examining the association between sedentary time and hepatic steatosis was performed. For each dependent variable, three separate models were calculated. Model 1 adjusted for age, sex, cohort (Third Generation vs Omni), current smoking status, alcohol use (drinks/week), accelerometer "wear time" in days; for the analysis examining the association between sedentary time and hepatic steatosis, we additionally adjusted for light PA and MVPA minutes/day. The second model contained the same covariates from model 1 and additionally adjusted for BMI. Model 3 adjusted for the covariates in model 1 and additionally adjusted for VAT. We also tested for effect modification by sex in the primary model.

To explore the association of PA and aminotransferase levels, multivariable-adjusted linear regression models examining the association between log-adjusted ALT and AST per 30 minutes/day increase in PA were performed. ALT and AST were natural log-transformed to normalize their skewed distribution.

Since hepatic steatosis is associated with obesity, we further characterized the association between MVPA, hepatic steatosis and BMI, by stratifying participants by BMI category (normal BMI (BMI \< 25 kg/m^2^), overweight (25 kg/m^2^ ≤ BMI \< 30 kg/m^2^) and obese (BMI ≥ 30 kg/m^2^)). We used the t-test for differences in means to determine if there were differences in the mean MVPA among those with hepatic steatosis (LPR ≤ 0.33) and those without hepatic steatosis (LPR \> 0.33) across the BMI categories and for obese (BMI ≥ 30 kg/m^2^) vs non-obese (BMI \< 30 kg/m^2^) participants.

A sensitivity analysis was conducted to assess the effect of using a less stringent definition of heavy alcohol use (defined as \>14 drinks per week for women and \>21 drinks per week for men) recommended by the American Association for the Study of Liver Diseases guidelines.([@R4])

Analyses were performed using SAS version 9.2 (SAS Institute, Cary, NC) software. A 2-tailed P value of \< 0.05 was considered significant.

Results {#S12}
=======

Study sample characteristics {#S13}
----------------------------

The characteristics of the study sample (mean age 50.5 ± 7.2 yrs, 47.3% women), by sex, are depicted in [Table 1](#T1){ref-type="table"}. On average, participants were overweight (mean BMI 28.4 ± 5.4 kg/m^2^) and 22.0% of women and 32.0% of men had a LPR ≤ 0.33 consistent with hepatic steatosis. On average, participants accumulated nearly 30 minutes/day of MVPA (26.6 ± 20.4 minutes of MVPA per day) and 14.5 ± 14.3 minutes of MVPA in bouts, defined as continuous MVPA of at least 10 minutes. Only 14.0% of women and 10.6% of men met the strict PA guideline of participating in ≥150 minutes/week of MVPA in bouts, while about 50% of participants engaged in ≥150 minutes/week of total MVPA. The average number of sedentary hours per day was 11.1 ± 1.1 (which excludes 8 hours of sleep) ([Table 1](#T1){ref-type="table"}). After adjusting for age, as expected, there was a moderate, positive correlation between more liver fat (− LPR) and VAT (r=0.50, p\<0.0001).

Correlations between accelerometer derived physical activity and metabolic parameters {#S14}
-------------------------------------------------------------------------------------

MVPA minutes/day was associated with most adiposity traits in women and men ([Table 2](#T2){ref-type="table"}). Specifically, increasing MVPA minutes/day was associated with lower BMI in women only (p\<0.001), waist circumference, and VAT volume and a higher liver attenuation (less liver fat) and log AST (all p\<0.05). Sedentary time was associated with VAT volume and log AST (p\<0.05) for women only.

Multivariable-adjusted regression models relating hepatic steatosis to physical activity {#S15}
----------------------------------------------------------------------------------------

In multivariable-adjusted models, there was an inverse association between PA and hepatic steatosis (LPR ≤ 0.33) ([Table 3](#T3){ref-type="table"}). Specifically, each 30 minute per day increase in MVPA was associated with a reduced odds of hepatic steatosis (OR= 0.62, p\<0.001). This association was attenuated and marginally significant after adjustment for BMI (OR = 0.77, p=0.05) and no longer significant after adjustment for VAT (OR = 0.83, p=0.18). Similar associations were found for MVPA performed in bouts. There was a significant sex interaction suggesting that associations between these factors was stronger in women compared to men ([Table 3](#T3){ref-type="table"}).

Multivariable-adjusted regression models relating hepatic steatosis to compliance with national physical activity guidelines {#S16}
----------------------------------------------------------------------------------------------------------------------------

For participants who met the national PA recommendations of engaging in ≥150 minutes/week of MVPA, the odds of hepatic steatosis was lower compared to those not meeting these recommendations, even after adjusting for BMI (OR=0.63, p=0.007) or VAT (OR=0.67, p=0.03) ([Table 4](#T4){ref-type="table"}). We found a significant sex interaction (p=0.02). The magnitude of the association of reduced odds of hepatic steatosis among participants compliant with the national PA guidelines was greater in women than in men, and remained statistically significant after adjustment for BMI or VAT in women only.

Multivariable-adjusted regression models relating hepatic steatosis to sedentary time {#S17}
-------------------------------------------------------------------------------------

There was not a statistically significant association between sedentary time and hepatic steatosis in any of the regression models ([Supplementary Table 1](#SD1){ref-type="supplementary-material"}).

Association between aminotransferase levels and physical activity {#S18}
-----------------------------------------------------------------

There were no associations with log ALT and increasing amounts of PA across all activity categories ([Supplementary Table 2](#SD1){ref-type="supplementary-material"}). However, for AST, for every 30 minute increase in MVPA minutes/day or MVPA bouts minutes/day and for those meeting the national PA guidelines, a significant positive association with log AST was observed.

Association of physical activity and hepatic steatosis by BMI category {#S19}
----------------------------------------------------------------------

The number of MVPA minutes/day accumulated per participant according to hepatic steatosis and BMI category are shown in [Figure 1](#F1){ref-type="fig"}. Participants with hepatic steatosis performed the least amount of MVPA minutes/day within BMI categories; however, the difference was only statistically significant in the overweight BMI category (p=0.02; MVPA normal weight hepatic steatosis vs non-hepatic steatosis p=0.25; MVPA obese hepatic steatosis vs non-hepatic steatosis p=0.48). Non-obese participants (BMI \< 30 kg/m^2^) without hepatic steatosis (n=609) performed more MVPA minutes/day (29.3 min/day) compared to non-obese participants with hepatic steatosis (n=102) (22.6 min/day) (p=0.002).

Secondary Analysis {#S20}
------------------

A secondary analysis adjusting the exclusion criteria to use a less stringent definition of heavy alcohol use([@R4]) was performed and the results of multivariable regression models were essentially unchanged (data not shown).

Discussion {#S21}
==========

Principle findings {#S22}
------------------

In this cross-sectional study in a large, unselected, community-based cohort, our findings are 3-fold. First, we observed that participants who engaged in higher levels of PA were less likely to have prevalent hepatic steatosis. Second, compliance with national PA guidelines was associated with the lowest odds of hepatic steatosis even in models adjusting for BMI. The magnitude of this association was stronger in women compared to men and remained statistically significant after adjusting for BMI or VAT in women only. Finally, there were no associations between sedentary time and hepatic steatosis.

In the context of the current literature {#S23}
----------------------------------------

There have been a number of small studies in select populations which have demonstrated improvements in hepatic steatosis in participants of structured exercise and weight loss programs.([@R5], [@R6], [@R7], [@R8], [@R9]) Little is currently known about the association of physical activity, outside of structured interventions, and NAFLD. Prior studies evaluating the association between PA and NAFLD have largely relied on self-reported PA assessments and our findings are in line with this prior work.([@R11], [@R12], [@R13], [@R14]) Self-reported PA data can be hampered by recall and response bias as well as the inability to accurately quantify PA levels.([@R24], [@R25]) To our knowledge, there has been only one other population-based study investigating objectively-measured PA and NAFLD that was conducted with the National Health and Nutrition Examination Survey (NHANES) data using a surrogate measure of NAFLD, the fatty liver index.([@R15]) This study found an association between NAFLD and lower PA in age- and sex-adjusted models. Our investigation advances the current literature by demonstrating that the association between hepatic steatosis and lower PA remains statistically significant after adjustments in a multivariable regression model, including BMI or VAT, but only for participants that engaged in ≥150 minutes per week of MVPA. This finding may indicate that there is a threshold of MVPA that must be exceeded before there are significant effects on liver fat. Additionally, our investigation further examined sedentary time and found no association with hepatic steatosis.

The current national guidelines for PA for all Americans recommend at least 150 minutes of moderate PA a week or 75 minutes of vigorous activity a week or a combination of both accrued in bouts of at least 10 minutes to improve and maintain health ([@R20]). There has been very little prior work specifically evaluating these guidelines in NAFLD. In a cohort of biopsy proven NAFLD, subjects who met vigorous activity recommendations had a significantly decreased adjusted-odds of NASH compared to those who did not meet the vigorous activity recommendations.([@R12]) This association was not seen for subjects who met the moderate-intensity PA recommendations. The authors conclude that intensity of PA, specifically vigorous activity, may be more important than duration or total volume of activity for the prevention or treatment of NASH. However, this study was limited by the use of self-reported leisure time only PA which tends to over-report MVPA and under-report sedentary time compared with objectively measured, accelerometer derived, PA measurements.([@R25], [@R26]) The amount of vigorous activity that participants in this study reported is likely an over-estimate since 26% of the sample met the vigorous PA guidelines, while in our investigation and others using accelerometer derived PA measurements, only 5.5% of participants met the vigorous PA guidelines.([@R26]) By using an accelerometer derived assessment of PA, we have evaluated an objective measure of adherence to the national PA guidelines.

We observed no association between sedentary time and hepatic steatosis which, to our knowledge, has not been previously demonstrated. Prior population-based studies have shown lower mortality from diabetes, cardiovascular disease and all-cause mortality with less sedentary time after adjusting for self-reported PA.([@R17], [@R18], [@R19]) There is evidence that interrupting sedentary time with 2 minute bouts of light or moderate activity every 20 minutes may decrease postprandial glucose and insulin levels in overweight and obese adults.([@R27]) We did not evaluate the effects of interrupted versus continuous sedentary time on hepatic steatosis, but this might be an interesting area of future investigation.

Potential mechanisms {#S24}
--------------------

Evidence from animal and human studies supports a benefit of exercise on hepatic fat content as well as skeletal muscle and adipose tissue deposits.([@R28]) In humans, exercise reduces plasma free fatty acids and decreases intrahepatic triglyceride content independent of weight loss.([@R5], [@R8]) Additionally, exercise likely also enhances insulin sensitivity in skeletal muscle thereby reducing insulin resistance which is highly correlated with NAFLD.([@R29]) Exercise may also contribute to differences in fatty acid uptake and utilization in the liver. Regular exercise increases the capacity for fatty acid uptake and oxidation within skeletal muscle which may help decrease the fatty acid burden in other tissues, including hepatocytes.([@R30]) Furthermore, exercise may directly augment hepatic fat by altering insulin-mediated intracellular utilization of fatty acids.([@R31])

We found significant sex interactions for hepatic steatosis and MVPA accrued in bouts and compliance with national PA guidelines where the effects were stronger in women compared to men. It is well-established that women and men have differences in fat distribution, with women having relatively lower VAT and higher SAT compared to men.([@R32], [@R33]) Additionally, increasing VAT and SAT volumes are associated with more adverse cardiovascular risk factors in women compared to men.([@R32]) Women have greater free fatty acid concentration and turn over compared to men which suggests sex differences in adipose tissue lipolysis.([@R34]) Prior population based studies have demonstrated sex differences in NAFLD prevalence. In a study which defined NAFLD based on ultrasound, men had a higher prevalence of NAFLD compared to women in adjusted models.([@R35]) Additionally, in the Dallas Heart Study which measured hepatic triglyceride content on magnetic resonance imaging, non-Hispanic white men had a 2-fold increased risk of fatty liver compared to non-Hispanic white women.([@R36]) This increased risk in men was not attributable to differences in body weight or insulin sensitivity and was not demonstrated in other ethnic groups.([@R36]) It is not known if differential effects of physical activity contribute to sex differences in hepatic steatosis. Prior studies evaluating sex differences on the effects of physical activity or exercise on fat metabolism are very limited.([@R30], [@R37]) In one small study, women were found to oxidize proportionally more lipid and less carbohydrate during exercise compared to men both before and after a 7 week endurance training program.([@R38]) It is possible that sex difference in exercise induced lipolysis may contribute to the overall stronger associations with PA and reduced prevalence of hepatic steatosis among women compared to men in our study.([@R31]) More research on potential sex differences of PA on hepatic steatosis are needed to further understand this interaction.

Implications {#S25}
------------

The intensity, amount and duration of PA required for the prevention and treatment of NAFLD is an important outstanding question since lifestyle modification remains the cornerstone of treatment.([@R4]) Currently, there is no standardized recommendation for PA in NAFLD patients. Although cross sectional, our investigation gives support for suggesting that compliance with the national PA guidelines of at least 150 minutes of moderate PA per week may be associated with less hepatic steatosis. Without objective measures, individuals may over-estimate their own physical activity, with larger differences between self-reported and accelerometer measured MVPA with higher levels of activity.([@R25]) In practice, it is possible that an individual may report that they meet the national PA guidelines; however, when their activity is measured objectively, they may no longer meet guideline recommendations.

Strengths and limitations {#S26}
-------------------------

The major strengths of our investigation include the use of a well-established and objective measure of PA. By taking advantage of a well-characterized, community-based sample, with standardized demographic, laboratory and anthropometric measurements, we are able to add to the current literature by adjusting for several important confounders in exploring the association with PA and hepatic steatosis. Additionally, our community based sample has not been selected for hepatic steatosis.

There are a number of important limitations to our investigation that deserve mention. First, this is a cross-sectional, observational study and therefore we cannot evaluate temporality and cannot make inferences about causality. Although accelerometry is a well-established measure of PA, because it is worn on the hip, it is has a limited ability to measure activities that are performed while the hip is stationary, such as swimming or bicycle riding, which may have resulted in non-differential misclassification, which would bias towards the null. Additionally, the temporally fixed sleep time appropriation methods may not fully represent the specific accelerometer wear patterns of the participants. An important assumption to acknowledge is that the majority of participants would be sleeping between the hours of 2200 and 0600 and we did not want this sedentary time to be counted with wakeful sedentary time. We estimated liver attenuation via CT imaging, which likely underrepresents the burden of hepatic steatosis in the population since CT imaging is non-specific and insensitive to mild steatosis compared to the gold standard of liver biopsy.([@R39]) This may have led to non-differential misclassification, biasing our results towards the null. Therefore, our findings may underrepresent the true association between hepatic steatosis and physical activity. Additionally, since CT scan lacks the sensitivity to detect mild liver steatosis (\<30% fat content), our study cannot evaluate the association between mild hepatic steatosis and physical activity. Since the LPR has a sensitivity of 70% for hepatic steatosis ([@R23]), this also has the potential to lead to non-differential misclassification, biasing our results towards the null. Additionally, CT imaging cannot accurately detect steatohepatitis so we are unable to determine the association of PA on fatty liver disease severity. Hepatic fat content can fluctuate rapidly with exercise and changes in weight. In this cross-sectional study, we are not able to measure the effects of PA and liver attenuation directly. We also lack information about viral hepatitis status and other chronic liver conditions which can cause the appearance of liver fat on CT scan. The seropositivity of hepatitis C is low in the general population (1--2%) so the possibility of confounding because of chronic hepatitis C in our population is low.([@R40]) Additionally, our sample is overwhelming Caucasian so the generalizability of our findings to individuals of non-European ancestry is not known.

Conclusion {#S27}
----------

In conclusion, we observed an inverse association between MVPA and hepatic steatosis. Participants who met the national PA guideline recommendations of engaging in at least 150 min/week of MVPA had a lower odds of hepatic steatosis, compared to those not reaching guideline recommendations. Future longitudinal studies using objectively measured PA assessments are required to further explore the role of PA for the prevention and treatment of hepatic steatosis.
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###### 

Characteristics of the study sample, by sex.

                                                                        Women (n=501)   Men (n=559)     Overall (n=1060)
  --------------------------------------------------------------------- --------------- --------------- ------------------
  Age (years)                                                           52.0 ± 7.2      49.2 ± 6.9      50.5 ± 7.2
  Sex (%)                                                               47.3            52.7            
  Cohort (%)                                                                                            
   Generation 3                                                         87.0            91.4            89.3
   Omni                                                                 13.0            8.6             10.7
  Race (%)                                                                                              
   White                                                                91.8            94.3            93.1
   African American                                                     3.4             2.1             2.7
   Asian                                                                4.0             2.9             3.4
   American Indian or Alaska Native                                     1.0             1.4             1.2
  Current Smoking (%)                                                   4.8             7.9             6.4
  Alcohol (drinks/week)                                                 1.8 ± 2.1       4.1 ± 4.1       3.0 ± 3.5
  Accelerometer wear time (min/day)                                     913.8 ± 92.4    937.9 ± 103.7   926.5 ± 99.2
  Sedentary activity (min/day)                                          674.3 ± 65.1    662.2 ± 69.6    667.9 ± 67.8
  Light activity (min/day)                                              126.0 ± 43.2    137.9 ± 52.5    132.3 ± 48.7
  Vigorous activity (min/day)                                           2.0 ± 5.7       1.8 ± 4.4       1.9 ± 5.0
  MVPA (min/day)                                                        24.2 ± 20.2     28.8 ± 20.4     26.6 ± 20.4
  MVPA in bouts (min/day)[\*](#TFN2){ref-type="table-fn"}               16.5 ± 16.1     12.7 ± 12.3     14.5 ± 14.3
  ≥ 150 min/week of MVPA (%)                                            42.5            56.5            49.9
  ≥ 150 min/week of MVPA in bouts (%)[\*](#TFN2){ref-type="table-fn"}   14.0            10.6            12.2
  ≥ 75 min/week vigorous activity (%)                                   5.4             5.5             5.5
  BMI (kg/m^2^)                                                         27.9 ± 6.2      28.8 ± 4.5      28.4 ± 5.4
  Waist Circumference (cm)                                              94.8 ± 15.2     101.8 ± 12.2    98.5 ± 14.2
  Visceral Adipose Tissue (cm^3^)                                       1489 ± 1003     2796 ± 1379     2178 ± 1379
  Liver Phantom Ratio                                                   0.35 ± 0.1      0.34 ± 0.1      0.34 ± 0.1
  Liver Phantom Ratio ≤ 0.33 (%)                                        22.0            32.0            27.3
  ALT (U/L)                                                             21 ± 17         31 ± 16         26 ± 17
  AST (U/L)                                                             21 ± 13         24 ± 11         22 ± 12

MVPA indicates moderate-to-vigorous physical activity; BMI, body mass index; ALT, alanine aminotransferase; AST, aspartate aminotransferase. Data are presented as the mean (SD) for continuous traits and percentage having that characteristic for categorical data.

A bout of MVPA is defined as at least 10 minutes of continuous MVPA allowing for a 2 minute interruption.

Data are in means ± standard deviation unless noted.

###### 

Sex specific, age-adjusted Pearson correlation coefficients between physical activity and metabolic parameters.

                        Women (n=501)                           Men (n=559)                                                                                                                                                                                                                       
  --------------------- --------------------------------------- ------------------------------------------- ------------------------------------------- ------------------------------------------- ------- ----------------------------------------- ------------------------------------------- ----------------------------------------
  Age (years)           0.04                                    −0.20[\*\*\*](#TFN7){ref-type="table-fn"}   −0.22[\*\*\*](#TFN7){ref-type="table-fn"}   −0.12[\*\*](#TFN6){ref-type="table-fn"}     −0.01   −0.13[\*\*](#TFN6){ref-type="table-fn"}   −0.18[\*\*\*](#TFN7){ref-type="table-fn"}   0.01
  BMI (kg/m^2^)         0.01                                    −0.08                                       −0.29[\*\*\*](#TFN7){ref-type="table-fn"}   −0.24[\*\*\*](#TFN7){ref-type="table-fn"}   −0.05   0.02                                      −0.05                                       −0.04
  Waist (cm)            0                                       −0.07                                       −0.27[\*\*\*](#TFN7){ref-type="table-fn"}   −0.23[\*\*\*](#TFN7){ref-type="table-fn"}   −0.03   −0.03                                     −0.08[\*](#TFN5){ref-type="table-fn"}       −0.04
  Liver Phantom Ratio   −0.03                                   0.09[\*](#TFN5){ref-type="table-fn"}        0.17[\*\*\*](#TFN7){ref-type="table-fn"}    0.18[\*\*](#TFN6){ref-type="table-fn"}      −0.02   0.10[\*](#TFN5){ref-type="table-fn"}      0.09[\*](#TFN5){ref-type="table-fn"}        0.05
  VAT Volume (cm^3^)    −0.09[\*](#TFN5){ref-type="table-fn"}   −0.01                                       −0.32[\*\*\*](#TFN7){ref-type="table-fn"}   −0.28[\*\*\*](#TFN7){ref-type="table-fn"}   0       −0.05                                     −0.12[\*\*](#TFN6){ref-type="table-fn"}     −0.07
  Log ALT (U/L)         0.04                                    0.04                                        −0.04                                       −0.07                                       0.02    −0.01                                     −0.01                                       0.02
  Log AST (U/L)         0.10[\*](#TFN5){ref-type="table-fn"}    0.06                                        0.19[\*\*\*](#TFN7){ref-type="table-fn"}    0.16[\*\*\*](#TFN7){ref-type="table-fn"}    0       0                                         0.06                                        0.12[\*\*](#TFN6){ref-type="table-fn"}

MVPA, moderate-to-vigorous physical activity; BMI indicates body mass index; VAT, visceral adipose tissue; ALT, alanine aminotransferase; AST, aspartate aminotransferase.

P-value \< 0.05

p-value \< 0.01

p-value \< 0.001

About of MVPA is defined as at least 10 minutes of continuous MVPA allowing for a 2 minute interruption.

###### 

Multivariable-adjusted logistic regressions examining the association between 30 minutes/day increment of physical activity and hepatic steatosis (Liver Phantom Ratio ≤ 0.33).

                                                                Women (n=501)       Men (n=559)   Overall (n=1060)    P Value for Sex Interaction                                
  ------------------------------------------------------------- ------------------- ------------- ------------------- ----------------------------- ------------------- -------- ------
  MVPA (minutes/day)                                                                                                                                                             0.08
   Multivariable (MV) Model[\*](#TFN10){ref-type="table-fn"}    0.42 (0.26--0.67)   0.0003        0.76 (0.57--1.02)   0.07                          0.62 (0.48--0.79)   0.0001   
   MV + BMI                                                     0.70 (0.43--1.13)   0.14          0.76 (0.55--1.04)   0.09                          0.77 (0.60--1.00)   0.05     
   MV + VAT                                                     0.88 (0.53--1.45)   0.60          0.87 (0.62--1.22)   0.42                          0.83 (0.63--1.09)   0.18     
  MVPA Bouts[\*\*](#TFN11){ref-type="table-fn"} (minutes/day)                                                                                                                    0.01
   MV Model[\*](#TFN10){ref-type="table-fn"}                    0.28 (0.14--0.59)   0.0007        0.87 (0.53--1.42)   0.58                          0.56 (0.38--0.83)   0.003    
   MV + BMI                                                     0.53 (0.26--1.10)   0.09          0.93 (0.55--1.59)   0.80                          0.80 (0.53--1.21)   0.29     
   MV + VAT                                                     0.73 (0.34--1.53)   0.40          0.99 (0.56--1.74)   0.97                          0.80 (0.52--1.23)   0.31     
  Light (minutes/day)                                                                                                                                                            0.68
   MV Model[\*](#TFN10){ref-type="table-fn"}                    0.88 (0.75--1.04)   0.13          0.88 (0.79--0.98)   0.02                          0.88 (0.80--0.96)   0.005    
   MV + BMI                                                     0.92 (0.77--1.10)   0.37          0.83 (0.73--0.94)   0.004                         0.86 (0.78--0.96)   0.005    
   MV + VAT                                                     0.91 (0.75--1.11)   0.36          0.87 (0.77--0.99)   0.04                          0.88 (0.79--0.98)   0.02     

BMI indicates body mass index; VAT, visceral adipose tissue

Multivariable (MV) Model includes age, sex (in overall model only), cohort (Third Generation or Omni), accelerometer wear time (valid days of use), current smoking status and drinks per week.

A bout of MVPA is defined as at least 10 minutes of continuous MVPA allowing for a 2 minute interruption.

###### 

Multivariable-adjusted logistic regressions examining the association between compliance with National physical activity guidelines for Americans and hepatic steatosis (Liver Phantom Ratio ≤ 0.33).

                                                                  Women (n=501)       Men (n=559)   Overall (n=1060)    P Value for Sex Interaction                                  
  --------------------------------------------------------------- ------------------- ------------- ------------------- ----------------------------- ------------------- ---------- ------
  Met MVPA Guidelines[\*\*](#TFN14){ref-type="table-fn"}                                                                                                                             0.02
   Multivariable (MV) Model[\*](#TFN13){ref-type="table-fn"}      0.29 (0.17--0.48)   \<0.0001      0.69 (0.47--1.00)   0.05                          0.49 (0.36--0.66)   \<0.0001   
   MV + BMI                                                       0.47 (0.26--0.84)   0.01          0.68 (0.45--1.05)   0.08                          0.63 (0.45--0.88)   0.007      
   MV + VAT                                                       0.55 (0.30--0.10)   0.05          0.82 (0.53--1.27)   0.37                          0.67 (0.47--0.95)   0.03       
  Met MVPA Bout Guidelines[\*\*\*](#TFN15){ref-type="table-fn"}                                                                                                                      0.02
   Multivariable (MV) Model[\*](#TFN13){ref-type="table-fn"}      0.20 (0.07--0.58)   0.003         0.89 (0.49--1.61)   0.69                          0.55 (0.34--0.89)   0.02       
   MV + BMI                                                       0.35 (0.12--1.07)   0.06          0.97 (0.50--1.88)   0.93                          0.75 (0.44--1.29)   0.30       
   MV + VAT                                                       0.44 (0.13--1.45)   0.18          1.02 (0.51--2.01)   0.97                          0.73 (0.41--1.29)   0.28       

BMI indicates body mass index; VAT, visceral adipose tissue

Multivariable (MV) Model includes age, sex (in overall model only), cohort (Third Generation or Omni), accelerometer wear time (valid days of use), current smoking status and drinks per week.

Met MVPA Guidelines is defined as participating in ≥ 150 minutes of moderate-to-vigorous physical activity per week.

Met MVPA Bout Guidelines is defined as participating in ≥ 150 minutes of moderate-to-vigorous physical activity per week accrued in bouts of at least 10 minutes.

What is already known about this subject? {#S30}
=========================================

-   Non-alcoholic fatty liver disease (NAFLD) is a common condition with few available treatments.

-   Guidelines recommend increasing physical activity in patients with NAFLD.

-   Most prior studies utilize subjective measures of physical activity.

What does this study add? {#S31}
=========================

-   There is an inverse association between objectively measured physical activity, outside of a structured exercise intervention, and hepatic steatosis.

-   Compliance with national physical activity guidelines may be associated with less hepatic steatosis.
